Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Early time-restricted eating to support postpartum weight loss

Official title: Use of Early Time-restricted Eating to Promote Weight Loss and Improve Cardiometabolic Health in Postpartum Women

Run by University of Alabama at Birmingham · NCT06491537 · Data updated 2026-11-12

This program will test whether an early time-restricted eating schedule helps postpartum women with overweight or obesity lose weight and is acceptable for them.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedMay 22, 2025
Main results expectedJanuary 1, 2029
Study endsFebruary 1, 2029
Registry record updatedJune 29, 2026
Trial IDNCT06491537 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are postpartum women 6–16 weeks after a healthy singleton birth with BMI ≥25 who can consent, communicate in English, and do not meet any exclusion criteria.

Probably not a fit

Patients with major medical conditions such as diabetes or renal disease, diagnosed eating disorders, current use of weight-altering medications, frequent overnight shift work, regular long fasting habits, or current participation in another dietary/weight program are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized two-arm trial will enroll 60 postpartum women (6–16 weeks after a healthy singleton birth) with BMI ≥25 and randomize them 1:1 to a 12-week early time-restricted eating (eTRE) intervention or a control group. The eTRE approach is adapted for postpartum life and limits daily eating to an earlier daily window, while the control arm receives usual care. Primary aims are to measure feasibility and acceptability of the intervention and trial procedures, with secondary comparisons of clinical outcomes (weight and cardiometabolic markers) and patient-reported outcomes. Participants with major medical conditions, diagnosed eating disorders, recent extensive fasting, or other exclusion criteria will be excluded from enrollment.

Why it matters

Potential benefit: If successful, this could offer a simple timing-based approach to help postpartum women with overweight or obesity lose weight and improve cardiometabolic health.

How similar studies have gone: Early time-restricted eating has shown cardiometabolic benefits in non-postpartum adult studies, but applying eTRE specifically in postpartum women is relatively novel and not well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years of age or older
* Experienced a healthy singleton pregnancy
* 6-16 weeks postpartum at enrollment
* Body mass index ≥25 at enrollment
* Willing to consent

Exclusion Criteria:

* Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes)
* Current treatment for severe psychiatric disorder (such as schizophrenia)
* Self-reported diagnosis of anorexia or bulimia
* Current use of medication expected to significantly impact body weight
* Current substance abuse
* Participation in another dietary and/or weight management intervention postpartum
* Performing overnight shiftwork \>1x/week
* Regularly fasting ≥14 hr/day or completing twelve or more 24-hr fasts within the past year
* Unable to understand and communicate in English

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

  • Principal investigator: Camille Worthington, PhD — University of Alabama at Birmingham
  • Study coordinator: Camille S Worthington, PhD
  • Email: cschneid@uab.edu
  • Phone: 205.975.7274

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.